110 related articles for article (PubMed ID: 11377325)
1. Analysis of three-dimensional ultrasound Doppler for the detection of prostate cancer.
Moskalik A; Carson PL; Rubin JM; Bree RL; Fowlkes JB; Rubin MA; Wojno K; Manley S; Montie JE
Urology; 2001 Jun; 57(6):1128-32. PubMed ID: 11377325
[TBL] [Abstract][Full Text] [Related]
2. Doppler quantitative measures by region to discriminate prostate cancer.
Potdevin TC; Moskalik AP; Fowlkes JB; Bude RO; Carson PL
Ultrasound Med Biol; 2001 Oct; 27(10):1305-10. PubMed ID: 11731043
[TBL] [Abstract][Full Text] [Related]
3. Analysis of three-dimensional Doppler ultrasonographic quantitative measures for the discrimination of prostate cancer.
Moskalik AP; Rubin MA; Wojno KJ; Bree R; Rubin JM; Fowlkes JB; Montie JE; Manley S; Carson PL
J Ultrasound Med; 2001 Jul; 20(7):713-22. PubMed ID: 11444729
[TBL] [Abstract][Full Text] [Related]
4. Targeted biopsy of the prostate: the impact of color Doppler imaging and elastography on prostate cancer detection and Gleason score.
Nelson ED; Slotoroff CB; Gomella LG; Halpern EJ
Urology; 2007 Dec; 70(6):1136-40. PubMed ID: 18158034
[TBL] [Abstract][Full Text] [Related]
5. The influence of prostate size on cancer detection.
Uzzo RG; Wei JT; Waldbaum RS; Perlmutter AP; Byrne JC; Vaughan ED
Urology; 1995 Dec; 46(6):831-6. PubMed ID: 7502425
[TBL] [Abstract][Full Text] [Related]
6. Color Doppler imaging in predicting the biologic behavior of prostate cancer: correlation with disease-free survival.
Ismail M; Petersen RO; Alexander AA; Newschaffer C; Gomella LG
Urology; 1997 Dec; 50(6):906-12. PubMed ID: 9426722
[TBL] [Abstract][Full Text] [Related]
7. Predictors of prostate carcinoma: accuracy of gray-scale and color Doppler US and serum markers.
Kuligowska E; Barish MA; Fenlon HM; Blake M
Radiology; 2001 Sep; 220(3):757-64. PubMed ID: 11526279
[TBL] [Abstract][Full Text] [Related]
8. High-frequency Doppler US of the prostate: effect of patient position.
Halpern EJ; Frauscher F; Forsberg F; Strup SE; Nazarian LN; O'Kane P; Gomella LG
Radiology; 2002 Mar; 222(3):634-9. PubMed ID: 11867778
[TBL] [Abstract][Full Text] [Related]
9. The application of three-dimensional contrast-enhanced ultrasound to measure volume of affected tissue after HIFU treatment for localized prostate cancer.
Sedelaar JP; Aarnink RG; van Leenders GJ; Beerlage HP; Debruyne FM; Wijkstra H; de La Rosette JJ
Eur Urol; 2000 May; 37(5):559-68. PubMed ID: 10765094
[TBL] [Abstract][Full Text] [Related]
10. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies.
Borboroglu PG; Comer SW; Riffenburgh RH; Amling CL
J Urol; 2000 Jan; 163(1):158-62. PubMed ID: 10604336
[TBL] [Abstract][Full Text] [Related]
11. Prostate: high-frequency Doppler US imaging for cancer detection.
Halpern EJ; Frauscher F; Strup SE; Nazarian LN; O'Kane P; Gomella LG
Radiology; 2002 Oct; 225(1):71-7. PubMed ID: 12354987
[TBL] [Abstract][Full Text] [Related]
12. Optimal combinations for detection of prostate cancer: systematic sextant and laterally directed biopsies versus systematic sextant and color Doppler-targeted biopsies.
Kravchick S; Cytron S; Peled R; London D; Sibi Y; Ben-Dor D
Urology; 2004 Feb; 63(2):301-5. PubMed ID: 14972476
[TBL] [Abstract][Full Text] [Related]
13. Effect of dutasteride therapy on Doppler US evaluation of prostate: preliminary results.
Ives EP; Gomella LG; Halpern EJ
Radiology; 2005 Oct; 237(1):197-201. PubMed ID: 16183933
[TBL] [Abstract][Full Text] [Related]
14. Contrast enhanced color Doppler endorectal sonography of prostate: efficiency for detecting peripheral zone tumors and role for biopsy procedure.
Roy C; Buy X; Lang H; Saussine C; Jacqmin D
J Urol; 2003 Jul; 170(1):69-72. PubMed ID: 12796647
[TBL] [Abstract][Full Text] [Related]
15. Using gray-scale and color and power Doppler sonography to detect prostatic cancer.
Halpern EJ; Strup SE
AJR Am J Roentgenol; 2000 Mar; 174(3):623-7. PubMed ID: 10701599
[TBL] [Abstract][Full Text] [Related]
16. Negative predictive value of systematic ultrasound-guided prostate biopsy: which tumours do we miss?
Köpke T; Oberpenning F; Bettendorf O; Eltze E; Herrmann E; Hertle L; Weining C; Wulfing C; Semjonow A
Anticancer Res; 2010 May; 30(5):1823-7. PubMed ID: 20592386
[TBL] [Abstract][Full Text] [Related]
17. Power doppler ultrasonography guided and random prostate biopsy in prostate cancer diagnosis - a comparative study.
Sohail SK; Sarfraz R; Imran M; Khan NA; Yusuf NW
J Pak Med Assoc; 2015 Jan; 65(1):65-8. PubMed ID: 25831678
[TBL] [Abstract][Full Text] [Related]
18. Endorectal color doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: correlation with radical prostatectomy findings.
Cornud F; Hamida K; Flam T; Hélénon O; Chrétien Y; Thiounn N; Correas JM; Casanova JM; Moreau JF
AJR Am J Roentgenol; 2000 Oct; 175(4):1161-8. PubMed ID: 11000183
[TBL] [Abstract][Full Text] [Related]
19. Transrectal doppler ultrasound during prostate biopsy: clinical utility and limitations.
Ezquer A; Ortega Hrescak MC; Sanagua C; Roggia-Rebullida P; López R; Cenice F; Veglia FH; Veglia F; Fernández A
Actas Urol Esp; 2015; 39(1):13-9. PubMed ID: 24630842
[TBL] [Abstract][Full Text] [Related]
20. Combined T2 and diffusion-weighted MR imaging with template prostate biopsies in men suspected with prostate cancer but negative transrectal ultrasound-guided biopsies.
Sheikh N; Wei C; Szewczyk-Bieda M; Campbell A; Memon S; Lang S; Nabi G
World J Urol; 2017 Feb; 35(2):213-220. PubMed ID: 27236302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
